SEC31A mutation affects ER homeostasis, causing a neurological syndrome

Area of Science:

• Genetics
• Molecular Biology
• Neuroscience

Background:

• Autosomal recessive syndrome characterized by intrauterine growth retardation, severe developmental delay, spastic quadriplegia, and early lethality by age 4.
• Affected individuals exhibited microcephaly, semilobar holoprosencephaly, and agenesis of the corpus callosum on brain MRI.
• The clinical presentation suggested a novel genetic etiology requiring molecular investigation.

Purpose of the Study:

• To elucidate the molecular basis of a severe autosomal recessive neurological syndrome.
• To identify the causative gene and understand the functional consequences of identified mutations.
• To investigate the role of SEC31A in cellular processes relevant to the disease phenotype.

Main Methods:

• Genome-wide linkage analysis and whole exome sequencing to identify disease-causing variants in affected kindred.
• Functional studies in Drosophila melanogaster utilizing the SEC31A orthologue.
• CRISPR/Cas9 gene editing to generate SEC31A knockout cell lines (SH-SY5Y, HEK293T) for molecular analysis.
• Quantitative reverse transcription PCR (qRT-PCR), immunoblotting, and cell viability assays were employed.

Main Results:

• A homozygous nonsense mutation in SEC31A was identified as the cause of the syndrome, leading to a functional null mutation via nonsense-mediated decay.
• Knockdown of SEC31A in Drosophila resulted in defective brains and early lethality, mirroring the human phenotype.
• SEC31A null mutant cells exhibited reduced viability and upregulated endoplasmic reticulum (ER) stress pathways, consistent with its role in the COP-II complex.

Conclusions:

• A null mutation in SEC31A is responsible for a severe human neurological syndrome.
• SEC31A dysfunction impairs protein transport via the COP-II complex, leading to ER stress and reduced cell viability.
• These findings highlight SEC31A's critical role in neuronal development and cellular homeostasis.